BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Lung cancer
,
Intestine
,
Holistic medicine
,
Quercetin
,
rs7903146
,
MYC
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
th</a> benefits
Summary
General Info
Curated Studies
Most Correlated Studies
There were no matches for th</a> benefits
Explore Curated Studies Results
Literature
Most Relevant Literature
Hypoxia-activated selectivity-improved anti-PKM2 antibody combined with prodrug TH-302 for potentiat…
Peripheral Th and NK cells are associated with response to lenvatinib plus PD-1 inhibitor in unresec…
Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastat…
Examining the Use and Benefits of Low-/Mild-Gain Hearing Aids in Service Members with Normal Hearing…
4. th Scientific Conferences UCM-ASEN "Functional and health benefits of the nutritional improvement…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
SARC021C: A Continuation Study of TH-CR-406/SARC021
Reduction of Exposure, Inflammation, and Oxidative Stress Following at Least 2 Years of Switching to…
A Phase 2 Biomarker - Enriched Study of TH-302 in Subjects With Advanced Melanoma
Study of the Safety and Efficacy of TH-302 in Combination With Gemcitabine Compared With Gemcitabine…
A Cardiac Safety Study of TH-302 in Patients With Advanced Solid Tumors
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ